Reduction of telomeric signals in murine melanoma and human breast cancer cell lines treated with 3′-azido-2′-3′-dideoxythymidine

International Journal of Oncology

Volumn 13, Issue 5, 1998, Pages 923-925

  Multani, Asha S ^a   Furlong, Cynthia ^a   Pathak, Sen ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

AZT; FISH; Human breast cancer cell line; Murine melanoma cell line; Telomerase; Telomere

Indexed keywords

ZIDOVUDINE;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TELOMERE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; DNA, NEOPLASM; ENZYME INHIBITORS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MELANOMA; METAPHASE; MICE; TELOMERASE; TELOMERE; TUMOR CELLS, CULTURED; ZIDOVUDINE;

EID: 0031792512     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.5.923     Document Type: Article

References (19)

1. Cheng YC, Dutschman GE, Bastow KF, Sarngadharan MG and Ting RYC: Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs. J Biol Chem 262: 2187-2189, 1987.
2. Furman PA, Fyfe JA, St-Clair MH, Weinbold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H and Barry DA: Phosphorylation of 3′-azido-3′ deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 83: 8333-8337, 1986.
3. Olivero OA and Poirier MC: Preferential incorporation of 3′-azido-2′,3′-dideoxythymidine (AZT) into telomeric DNA and Z-DNA-containing regions of Chinese hamster ovary cells. Mol Carcinog 8: 81-88, 1993.
4. Olivero OA, Beland FA and Poirier MC: Immunofluorescent localization and quantitation of 3′-azido-2′,3′-dideoxythymidine (AZT) incorporated into chromosomal DNA of human, hamster and mouse cell lines. Int J Oncol 4: 49-54, 1994.
5. Gomez DE, Kassim A and Olivero OA: Preferential incorporation of 3′-azido-2′,3′-dideoxythymidine (AZT) in telomeric sequences of CHO cells. Int J Oncol 7: 1057-1060, 1995.
6. Strahl C and Blackburn EH: The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena. Nucleic Acids Res 22: 893-900, 1994.
7. Strahl C and Blackburn EH: Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 16: 53-65, 1996.
8. Multani AS, Hopwood VL and Pathak S: A modified fluorescence in situ hybridization (FISH) technique. Anticancer Res 16: 3435-3438, 1996.
9. Kipling D and Cook HJ: Hypervariable ultra-long telomeres in mice. Nature 347: 400-402, 1990.
10. Pathak S, Risin S, Brown NM and Berry K: Telomeric association of chromosomes is an early manifestation of programmed cell death. Int J Oncol 4: 323-328, 1994.
11. Pathak S, Dave BJ and Gagos SH: Chromosome alterations in cancer development and apoptosis. In vivo 8: 843-850, 1994.
12. Pathak S, Multani AS and Amoss MS Jr: Telomere, telomerase and malignant melanomas in human and domestic mammals. Arch Zootech 45: 141-149, 1996.
13. Harley CB, Futcher AB and Greider CW: Telomeres shorten during aging of human fibroblasts. Nature 345: 458-460, 1990.
14. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RC: Telomere reduction in human colorectal carcinoma and with aging. Nature 346: 866-868, 1990.
15. Shay JW, Wright WE and Wergin H: Loss of telomeric DNA during aging may predispose cells to cancer (Review). Int J Oncol 3: 559-563, 1993.
16. De Lange T: Telomere dynamics and genome instability in human cancer. In: Telomeres. Blackburn EH and Greider CW (eds). Cold Harbor Laboratory, Cold Spring Harbor, NY, pp265-293, 1995.
17. Lundblad V: The end replication problem: more than one solution. Nat Med 3: 1198-1199, 1997.
18. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA and Reddel RR: Evidence for an alternative mechanism for elongating telomeres in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274, 1997.
19. Gomez DE, Tejera AM and Olivera OA: Irreversible telomere shortening by 3′-azido-2′3′-dideoxythymidine (AZT) treatment. Biochem Biophys Res Commun 246: 107-110, 1998.